Blog
RSS FeedPosted by Michael Wonder on 12 Jul 2021
SMC - July 2021 decisions
12 July 2021 - The SMC has today published advice accepting three new medicines. ...
Posted by Michael Wonder on 10 May 2021
Medicines for colorectal, skin and ovarian cancers approved for NHS Scotland use
10 May 2021 - The Scottish Medicines Consortium accepted a treatment of colorectal cancer in patients with a gene mutation called ...
Posted by Michael Wonder on 20 Jan 2021
Scotland backs Roche’s Rozlytrek for ROS1 lung cancer
19 January 2021 - The Scottish Medicines Consortium has given a green light to Roche’s Rozlytrek for a rare form ...
Posted by Michael Wonder on 18 Jan 2021
SMC - January 2021 decisions
18 January 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 14 Oct 2020
Scotland backs two myeloma drugs turned down by NICE in England
14 October 2020 - A north-south divide threatens to emerge in multiple myeloma in the UK, after the Scottish Medicines ...
Posted by Michael Wonder on 12 Oct 2020
SMC accepts Bavencio (avelumab) in combination with axitinib for the first-line treatment of adult patients with advanced or metastatic renal cell carcinoma
12 October 2020 - Merck and Pfizer announced today that the Scottish Medicines Consortium has accepted the immunotherapy Bavencio (avelumab) for ...
Posted by Michael Wonder on 08 Sep 2020
ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’
7 September 2020 - The Institute of Cancer Research, London, has welcomed the approval by the Scottish Medicines Consortium of ...
Posted by Michael Wonder on 07 Sep 2020
SMC recommends Merck's Keytruda for another two indications
7 September 2020 - Pembrolizumab (Keytruda) has been accepted for the treatment of patients with head and neck squamous cell carcinoma ...
Posted by Michael Wonder on 10 Dec 2019
Ovarian cancer drug olaparib approved in Scotland as new treatment
9 December 2019 - A maintenance treatment for patients with advanced ovarian cancer has been approved for use in Scotland. ...
Posted by Michael Wonder on 11 Nov 2019
Breast and kidney cancer drugs get approval for use across Scotland's NHS
11 November 2019 - Medicines for breast and kidney cancers are among five new drugs which can now be used ...
Posted by Michael Wonder on 08 Jul 2019
New treatment approved for patients with breast cancer in Scotland
8 July 2019 - A new drug for patients with advanced breast cancer has been approved for use by the ...
Posted by Michael Wonder on 08 Jul 2019
SMC - July 2019 decisions
8 July 2019 - A medicine used to treat advanced breast cancer has today been accepted by the Scottish Medicines ...
Posted by Michael Wonder on 13 May 2019
New cancer drugs approved for NHS use in Scotland
13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...
Posted by Michael Wonder on 12 Mar 2019
SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma
11 March 2019 - Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS ...
Posted by Michael Wonder on 12 Feb 2019
Yescarta rejected among other SMC decisions
12 February 2019 - Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for ...